Home
Novo Holdings A/S reported a 6.8% stake in 4D Molecular Therapeutics FDMT · 3,175,000 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 6.8%
- Last report
- First report
- Shares held
- 3,175,000 sh
- Class
- Common Stock, par value $0.0001 per share
- Holder
- Novo Holdings A/S
- Event date
- 25/10/13
- Filed
- 25/10/20
First 5%+ report · 6.8% stake
4D Molecular Therapeutics trades, last 26 weeks
What else happened in 4D Molecular Therapeutics around then
Filed or reported within 30 days of the trade day · 25/09/13~25/11/12Novo Holdings A/S's other 5% stake reports
- Novo Holdings A/S
5% stakeHemab Therapeutics Holdings
5% stakeHemab Therapeutics Holdings
COAG
9% stake
4,180,550 sh
9% stake
Filed 08/14
- Novo Holdings A/S
5% stakeAvalyn Pharma
5% stakeAvalyn Pharma
AVLN
8.8% stake
3,883,289 sh
8.8% stake
Filed 08/14
- Novo Holdings A/S
5% stakeObsidian Therapeutics
5% stakeObsidian Therapeutics
OBX
5.1% stake
3,123,992 sh
5.1% stake
Filed 08/10
- Novo Holdings A/S
5% stakeMapLight Therapeutics
5% stakeMapLight Therapeutics
MPLT
4.9% stake
2,086,622 sh
4.9% stake
Filed 07/31
- Novo Holdings A/S
5% stakeEdgewise Therapeutics
5% stakeEdgewise Therapeutics
EWTX
4.9% stake
5,350,000 sh
4.9% stake
Filed 04/27
